Cytomegalovirus (CMV) glycoprotein H-based serological analysis in Japanese healthy pregnant women, and in neonates with congenital CMV infection and their mothers

Journal of Clinical Virology

Volumn 58, Issue 2, 2013, Pages 474-478

  Ikuta, Kazufumi ^a   Minematsu, Toshio ^b   Inoue, Naoki ^c   Kubo, Takahiko ^d   Asano, Kimisato ^a   Ishibashi, Kei ^a   Imamura, Takashi ^a   Nakai, Hidetaka ^e   Yoshikawa, Tetsushi ^e   Moriuchi, Hiroyuki ^f   Fujiwara, Shigeyoshi ^g   Koyano, Shin ^h   Suzutani, Tatsuo ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b Aisenkai Nichinan Hospital   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^d NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^e FUJITA HEALTH UNIVERSITY   (Japan)

^f NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g National Maritime Research Institute   (Japan)

^h ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Congenital infection; Cytomegalovirus; IgG subclasses

Indexed keywords

EPITOPE; GLYCOPROTEIN; GLYCOPROTEIN B; GLYCOPROTEIN H; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G3 ANTIBODY; UNCLASSIFIED DRUG; VALGANCICLOVIR;

ARTICLE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; FEMALE; GENOTYPE; HUMAN; INFECTION RISK; JAPANESE; MAJOR CLINICAL STUDY; MOTHER; NEWBORN; PRIORITY JOURNAL; SCREENING; SEROLOGY; SEROPREVALENCE; SEROTYPE; VIRUS STRAIN;

CONGENITAL INFECTION; CYTOMEGALOVIRUS; IGG SUBCLASSES;

ANTIBODIES, VIRAL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GENOTYPE; HUMANS; IMMUNOGLOBULIN G; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; JAPAN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANT WOMEN; SEROEPIDEMIOLOGIC STUDIES; SEROTYPING; VIRAL ENVELOPE PROTEINS;

EID: 84884530911     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2013.07.004     Document Type: Article

References (45)

1. Stagno S., Whitley R.J. Herpesvirus infections of pregnancy, part I: cytomegalovirus and Epstein-Barr virus infections. N Engl J Med 1985, 313:1270-1274.
2. Britt W. Manifestations of human cytomegalovirus infection: proposed mechanisms of acute and chronic disease. Curr Top Microbiol Immunol 2008, 325:417-470.
3. Gaytant M.A., Steegers E.A., Semmekrot B.A., Merkus H.M., Galama J.M. Congenital cytomegalovirus infection: review of the epidemiology and outcome. Obstet Gynecol Surv 2002, 57:245-256.
4. Dahle A.J., Fowler K.B., Wright J.D., Boppana S.B., Britt W.J., Pass R.F. Longitudinal investigation of hearing disorders in children with congenital cytomegalovirus. J Am Acad Audiol 2000, 11:283-290.
5. Dahle A.J., McCollister F.P., Hamner B.A., Reynolds D.W., Stagno S. Subclinical congenital cytomegalovirus infection and hearing impairment. J Speech Hear Disord 1974, 39:320-329.
6. Reynolds D.W., Stagno S., Stubbs K.G., Dahle A.J., Livingston M.M., Saxon S.S., et al. Inapparent congenital cytomegalovirus infection with elevated cord IgM levels, Casual relation with auditory and mental deficiency. N Engl J Med 1974, 290:291-296.
7. Medearis D.N. Observations concerning human cytomegalovirus infection and disease. Bull Johns Hopkins Hosp 1964, 114:181-211.
8. Boppana S.B., Rivera L.B., Fowler K.B., Mach M., Britt W.J. Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N Engl J Med 2001, 344:1366-1371.
9. Puchhammer-Stööckl E., Göörzer I. Human cytomegalovirus: an enormous variety of strains and their possible clinical significance in the human host. Future Virol 2011, 6:259-271.
10. Ross S.A., Arora N., Novak Z., Fowler K.B., Britt W.J., Boppana S.B. Cytomegalovirus reinfections in healthy seroimmune women. J Infect Dis 2010, 201:386-389.
11. Ross S.A., Novak Z., Ashrith G., Rivera L.B., Britt W.J., Hedges S., et al. Association between genital tract cytomegalovirus infection and bacterial vaginosis. J Infect Dis 2005, 192:1727-1730.
12. Bale J.F., Petheram S.J., Souza I.E., Murph J.R. Cytomegalovirus reinfection in young children. J Pediatr 1996, 128:347-352.
13. Grosjean J., Hantz S., Cotin S., Baclet M.C., Mengelle C., Trapes L., et al. Direct genotyping of cytomegalovirus envelope glycoproteins from toddler's saliva samples. J Clin Virol 2009, 46(Suppl 4):S43-S48.
14. Novak Z., Ross S.A., Patro R.K., Pati S.K., Kumbla R.A., Brice S., et al. Cytomegalovirus strain diversity in seropositive women. J Clin Microbiol 2008, 46:882-886.
15. Chandler S.H., Handsfield H.H., McDougall J.K. Isolation of multiple strains of cytomegalovirus from women attending a clinic for sexually transmitted disease. J Infect Dis 1987, 155:655-660.
16. Meyer-Konig U., Ebert K., Schrage B., Pollak S., Hufert F.T. Simultaneous infection of healthy people with multiple human cytomegalovirus strains. Lancet 1998, 352:1280-1281.
17. Gorzer I., Kerschner H., Redlberger-Fritz M., Puchhammer-Stockl E. Human cytomegalovirus (HCMV) genotype populations in immunocompetent individuals during primary HCMV infection. J Clin Virol 2010, 48:100-103.
18. Hansen S.G., Powers C.J., Richards R., Ventura A.B., Ford J.C., Siess D., et al. Evasion of CD8+ T cells is critical for superinfection by cytomegalovirus. Science 2010, 328:102-106.
19. Klein M., Schoppel K., Amvrossiadis N., Mach M. Strain-specific neutralization of human cytomegalovirus isolates by human sera. J Virol 1999, 73:878-886.
20. Burkhardt C., Himmelein S., Britt W., Winkler T., Mach M. Glycoprotein N subtypes of human cytomegalovirus induce a strain-specific antibody response during natural infection. J Gen Virol 2009, 90:1951-1961.
21. Ishibashi K., Tokumoto T., Tanabe K., Shirakawa H., Hashimoto K., Kushida N., et al. Association of the outcome of renal transplantation with antibody response to cytomegalovirus strain-specific glycoprotein H epitopes. Clin Infect Dis 2007, 45:60-70.
22. Ikuta K., Ishioka K., Sato Y., Imamura T., Asano K., Koyano S., et al. A novel real-time PCR method for determination and quantification of each cytomegalovirus glycoprotein H subtype in clinical samples. J Clin Microbiol 2012, 50:499-501.
23. Koyano S., Inoue N., Oka A., Moriuchi H., Asano K., Ito Y., Yamada H., Yoshikawa T., Suzutani T., for the Group JCCS Screening for congenital cytomegalovirus infection using newborn urine samples collected on filter paper: feasibility and outcomes from a multicentre study. BMJ Open 2011, in press.
24. Imamura T., Suzutani T., Ogawa H., Asano K., Nomoto M., Matsui T., et al. Oral valganciclovir treatment for congenital cytomegalovirus infection. Pediatr Int 2011, 53:249-252.
25. Fukushima E., Ishibashi K., Kaneko H., Nishimura H., Inoue N., Tokumoto T., et al. Identification of a highly conserved region in the human cytomegalovirus glycoprotein H gene and design of molecular diagnostic methods targeting the region. J Virol Methods 2008, 151:55-60.
26. Blackburn N.K., Besselaar T.G., Schoub B.D., O'Connell K.F. Differentiation of primary cytomegalovirus infection from reactivation using the urea denaturation test for measuring antibody avidity. J Med Virol 1991, 33:6-9.
27. Fowler K.B., Stagno S., Pass R.F. Maternal immunity and prevention of congenital cytomegalovirus infection. Jama 2003, 289:1008-1011.
28. Turner M. Antibodies and their receptors. Immunology. 1996, 4.1-10. Times Mirror International Publishers Limited, London. 4th ed. I. Roitt, J. Brostoff, D. Male (Eds.).
29. Gilljam G., Wahren B. Properties of IgG subclasses to human cytomegalovirus. J Virol Methods 1989, 25:139-151.
30. Gupta C.K., Leszczynski J., Gupta R.K., Siber G.R. IgG subclass antibodies to human cytomegalovirus (CMV) in normal human plasma samples and immune globulins and their neutralizing activities. Biologicals 1996, 24:117-124.
31. Urban M., Winkler T., Landini M.P., Britt W., Mach M. Epitope-specific distribution of IgG subclasses against antigenic domains on glycoproteins of human cytomegalovirus. J Infect Dis 1994, 169:83-90.
32. Bate S.L., Dollard S.C., Cannon M.J. Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988-2004. Clin Infect Dis 2010, 50:1439-1447.
33. Krech U. Complement-fixing antibodies against cytomegalovirus in different parts of the world. Bull World Health Organ 1973, 49:103-106.
34. Rosenthal S.L., Stanberry L.R., Biro F.M., Slaoui M., Francotte M., Koutsoukos M., et al. Seroprevalence of herpes simplex virus types 1 and 2 and cytomegalovirus in adolescents. Clin Infect Dis 1997, 24:135-139.
35. Nishimura N., Kimura H., Yabuta Y., Tanaka N., Ito Y., Ishikawa K., et al. Prevalence of maternal cytomegalovirus (CMV) antibody and detection of CMV DNA in amniotic fluid. Microbiol Immunol 1999, 43:781-784.
36. Staras S.A., Dollard S.C., Radford K.W., Flanders W.D., Pass R.F., Cannon M.J. Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. Clin Infect Dis 2006, 43:1143-1151.
37. Urban M., Britt W., Mach M. The dominant linear neutralizing antibody-binding site of glycoprotein gp86 of human cytomegalovirus is strain specific. J Virol 1992, 66:1303-1311.
38. Ishibashi K., Tokumoto T., Shirakawa H., Hashimoto K., Kushida N., Yanagida T., et al. Strain-specific seroepidemiology and reinfection of cytomegalovirus. Microbes Infect 2008, 10:1363-1369.
39. Murthy S., Hayward G.S., Wheelan S., Forman M.S., Ahn J.H., Pass R.F., et al. Detection of a single identical cytomegalovirus (CMV) strain in recently seroconverted young women. PLoS One 2011, 6:e15949.
40. Yamamoto A.Y., Mussi-Pinhata M.M., Boppana S.B., Novak Z., Wagatsuma V.M., Oliveira Pde F., et al. Human cytomegalovirus reinfection is associated with intrauterine transmission in a highly cytomegalovirus-immune maternal population. Am J Obstet Gynecol 2010, 202(297):e1-e8.
41. Mussi-Pinhata M.M., Yamamoto A.Y., Moura Brito R.M., de Lima Isaac M., de Carvalho e Oliveira P.F., Boppana S., et al. Birth prevalence and natural history of congenital cytomegalovirus infection in a highly seroimmune population. Clin Infect Dis 2009, 49:522-528.
42. Dar L., Pati S.K., Patro A.R., Deorari A.K., Rai S., Kant S., et al. Congenital cytomegalovirus infection in a highly seropositive semi-urban population in India. Pediatr Infect Dis J 2008, 27:841-843.
43. Stagno S., Reynolds D.W., Huang E.S., Thames S.D., Smith R.J., Alford C.A. Congenital cytomegalovirus infection. N Engl J Med 1977, 296:1254-1258.
44. Schopfer K., Lauber E., Krech U. Congenital cytomegalovirus infection in newborn infants of mothers infected before pregnancy. Arch Dis Child 1978, 53:536-539.
45. Stagno S., Pass R.F., Dworsky M.E., Henderson R.E., Moore E.G., Walton P.D., et al. Congenital cytomegalovirus infection: The relative importance of primary and recurrent maternal infection. N Engl J Med 1982, 306:945-949.